12/1/2025 On November 6, 2025, the Trump administration announced a landmark agreement with pharmaceutical manufacturers Eli Lilly and Novo Nordisk to provide steep discounts on their most popular GLP-1 medications, cuts that will benefit Medicare and Medicaid enrollees as well as cash-paying patients
Berra CC, Rossi MC, Mirani M, et al
Goal-Oriented Mindset People with T2D are typically prescribed GLP-1s to stimulate their pancreas and to ward off worsening symptoms that may lead them to require using insulin down the line
27 , 33713384.e3 (2019)
Animal studies using the gold-standard euglycemic clamp technique confirmed that even chronic AOD-9604 treatment produced no adverse effects on insulin sensitivity, despite significant fat loss occurring
With her health issues caused by or exacerbated by obesity, Michelle says her body felt like something "other" that was out of her control